Abstract

Nifedipine is an antihypertensive BCS class II drug which has poor bioavailability when given orally. The objective of the present study was to increase the bioavailability of nifedipine, by formulation and evaluation of a buccoadhesive liquisolid system using magnesium aluminium silicate (Neusilin) as both carrier and coating material and dissolution media were selected based on the solubility studies. A mixture of carboxymethylcellulose sodium and carbomer was used as mucoadhesive polymers. Buccoadhesive tablets were prepared by direct compression. FTIR studies confirmed no interaction between drug and excipients. XRD studies indicated change/reduction in crystallinity of drug. The powder characteristics were evaluated by different flow parameters to comply with pharmacopoeial specifications. The dissolution studies for liquisolid compacts and tablet formulations were carried out and it was found that nifedipine liquisolid tablets formulated from bioadhesive polymers containing 49% liquisolid system, 17.5% carbomer, and 7.5% carboxymethylcellulose sodium showed the best results in terms of dissolution properties. Prepared formulation batches were evaluated for swelling, bioadhesion strength, ex vivo residence time, and permeability studies. The optimized batch was showing promising features of the system. Formulating nifedipine as a buccoadhesive tablet allows reduction in dose and offers better control over the plasma levels.

Highlights

  • Amongst various techniques available for solubility enhancement of poorly soluble drugs, powdered liquid technology is comparatively less explored

  • Liquisolid system containing the drug was incorporated into a matrix containing buccoadhesive polymers to formulate a buccoadhesive tablet

  • Fourier Transform Infrared Spectroscopy (FTIR) spectroscopy helps to determine any chemical interaction between drug and excipients used in formulation

Read more

Summary

Introduction

Amongst various techniques available for solubility enhancement of poorly soluble drugs, powdered liquid technology is comparatively less explored. Liquisolid technology has been applied to improve dissolution of various poorly water soluble drugs [2,3,4,5]. Drugs with poor water solubility and high first pass metabolism are difficult to deliver effectively, because gastrointestinal route must be avoided to avoid first pass metabolism. Since the drug is poorly soluble, it is less likely to be released effectively at the buccal mucosal membrane. In such case, a solubility enhancing technique such as the liquisolid approach can be helpful to improve absorption efficiency

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call